OpenAlex
PricingAboutJobs
Log inGet started
Author

Żaneta Witas

Institution: Medical University of Lodz
Observed institution: Medical University of Lodz
ORCID: 0009-0000-0857-4816
Observed ORCID: 0009-0000-0857-4816
OpenAlex ID: A5114509186
Predictors and Profile of Severe Infectious Complications in Multiple Myeloma Patients Treated with Daratumumab-Based Regimens: A Machine Learning Model for Pneumonia Risk
2024 · Damian Mikulski, Marcin Kamil Kędzior, et al. · Cancers · 6
PDF
Real-world utility of platelet count, hemoglobin, and iron levels as predictors of clinical response to vedolizumab in patients with ulcerative colitis: a retrospective, single-center study in Poland
2026 · Aleksandra Sobolewska-Włodarczyk, Jakub Orliński, et al. · BMC Gastroenterology
Daratumumab–lenalidomide–dexamethasone (DRd) vs. lenalidomide–dexamethasone in patients with relapsed/refractory multiple myeloma — Polish early real-world experience following DRd reimbursement in the B.54 drug program
2025 · Julia Piotrowska, Katarzyna Płoszka, et al. · Acta Haematologica Polonica
PDF
Works count: 3
Citation count: 6
H-index: 1
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security